All Kits & Reagents
Improved Q30 score, support for UMIs, extended shelf life, and support for Illumina DNA PCR-Free Library Prep
All Selection & Planning Tools
Filter by batch size, system, software, and more. Compare and cart products.
All Software & Informatics Products
Enable insights and variant interpretation for diverse genomic testing applications at scale
Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification
All Popular Products
New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more
Understanding cardiovascular diseases through genomic sequencing
All Informatics Education
More About Us
Empower the next generation of scientists and engineers through educational opportunities and resources
More Career Info
All Investor Information
More Business Solutions
All Legal Information
Get instructions for using DRAGEN Secondary Analysis v4.0
All Support Tools
All Product Support Services
Linking the causes and consequences of complex phenotypes through multiomics
All Cancer Research Products
All Microbial Genomics Research
Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply
All Microbial Genomics Products
All Informatics Products
More than just a sweet treat, sugarcane can also be a source of greener energy
All Agrigenomics Products
All Complex Disease Research Products
The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab
All Reproductive Health
All Reproductive Health Products
Illumina Complete Long Read technology enables both long and short reads on the same NovaSeq instrument
All Genetic Health Products
Using a single test assessing hundreds of current and
emerging cancer biomarkers, you can now access a
clinically relevant report with actionable answers.
The MiSeqDx instrument is the first FDA-cleared <i>in vitro</i> diagnostic (IVD) next-generation sequencing (NGS) system.
MiSeqDx applications include FDA-cleared and FDA-approved assays for cystic fibrosis testing, colorectal cancer evaluation, and NGS-based assay development.
FDA-cleared next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.